Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire
Fierce Pharma
Thu, 01/6/22 - 11:52 am
Tags:
Amgen, AstraZeneca, Broad Institute, asthma, Tezspire, drug names
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Pharmaceutical Business Review
Tue, 01/4/22 - 10:16 am
Tags:
Ovid Therapeutics, AstraZeneca, small molecule drugs, epilepsy
AstraZeneca, Ionis close deal on antisense therapy development
Pharmaceutical Business Review
Thu, 12/30/21 - 11:07 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, antisense, eplontersen
AstraZeneca and Amgen’s asthma biologic approved in the US
Biopharma Reporter
Mon, 12/20/21 - 11:08 am
Tags:
AstraZeneca, Amgen, Tezspire, FDA, severe asthma
Go or no go? Roche’s fresh start for a new year
EP Vantage
Mon, 12/20/21 - 10:59 am
Tags:
FDA, Roche, Novartis, Pfizer, AstraZeneca, Cibinqo, Lynparza, Tezspire, Vyvgart, faricimab
This New Study Could Give Moderna a Big Advantage in 2022
Motley Fool
Sat, 12/18/21 - 10:46 pm
Tags:
Moderna Therapeutics, Pfizer, AstraZeneca, COVID-19, vaccines, boosters
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Tags:
Viatris, generics, Symbicort, AstraZeneca, patents, COPD, asthma
2021: the year mRNA therapeutics came of age
Pharmaforum
Mon, 12/13/21 - 10:55 am
Tags:
MRNA, vaccines, COVID-19, Sanofi, AstraZeneca, Moderna Therapeutics, Pfizer, BioNTech
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure
Fierce Pharma
Wed, 12/8/21 - 11:35 pm
Tags:
AstraZeneca, COVID-19, antibodies, FDA, Emergency Use Authorization
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
Tags:
AstraZeneca, Daiichi Sankyo, Gilead Sciences, Trodelvy, triple negative breast cancer, Dato-DXd
AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug
BioPharma Dive
Tue, 12/7/21 - 10:48 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, transthyretin amyloidosis, eplontersen
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg
Fierce Pharma
Mon, 12/6/21 - 10:56 am
Tags:
AstraZeneca, spinoffs, COVID-19, vaccines
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Motley Fool
Sun, 12/5/21 - 10:47 pm
Tags:
Moderna Therapeutics, AstraZeneca, AZD-8601, heart failure, MRNA
Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines
Endpoints
Fri, 12/3/21 - 10:57 am
Tags:
JNJ, AstraZeneca, blood clots, vaccines, COVID-19
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
Tags:
AstraZeneca, Alexion, Sobi, M&A
AstraZeneca to Scrap Plan for U.S. Covid Booster Study
Bloomberg
Thu, 12/2/21 - 11:00 pm
Tags:
AstraZeneca, vaccines, COVID-19, boosters, clinical trials
FDA grants priority review to AstraZeneca’s sNDA for breast cancer therapy
Pharmaceutical Business Review
Wed, 12/1/21 - 10:21 am
Tags:
FDA, AstraZeneca, Lynparza, BRCA-mutant breast cancer
AstraZeneca opens new advance therapeutics R&D facility in Cambridge
Biopharma Reporter
Tue, 11/23/21 - 10:03 am
Tags:
AstraZeneca, Cambridge, UK, R&D
Passive vaccination? AstraZeneca spotlights six-month protection with Covid-19 antibody among vulnerable group
Endpoints
Thu, 11/18/21 - 10:44 am
Tags:
AstraZeneca, COVID-19, antibodies, passive vaccination
Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure
Seeking Alpha
Mon, 11/15/21 - 12:27 pm
Tags:
Moderna Therapeutics, MRNA, AstraZeneca, clinical trials, heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.